Sermorelin.

A 29-amino-acid fragment of growth-hormone-releasing hormone, given as a small nightly subcutaneous injection. It prompts the pituitary to release growth hormone on its own rhythm rather than supplying the hormone itself — under doctor or clinician guidance.

$159 / month

Includes consultation · vial · syringes · sharps return

Payment is collected before clinical review. GEN displays the total due today at checkout. A prescription is not guaranteed.

ClassGHRH 1-29 fragment

RouteSubcutaneous

CompoundC149H246N44O42S

Mol. weight3357.9 g/mol

Doctor- or clinician-approvedCompounded to orderThird-party testedCancel anytime

All 50 states

Chain of custody

Who handles your medication, at every step.

PRESCRIBED

Your doctor or clinician

DEA-registered · state-licensed

Issued at consult

COMPOUNDED

503A / 503B partner pharmacy

State-licensed facility

To your prescription

TESTED

Independent lab

Sterility · potency · endotoxin

Before release

RELEASED

Licensed pharmacist

Signs the batch record

Before shipping

Indications

Considered for adults with

Adults working with a prescriber on age-related decline in GH-axis output
Poor sleep depth, as one part of a supervised plan
Recovery and body-composition goals, on doctor or clinician judgment
Adults who want the GH axis supervised rather than supplemented

Counter-indications

Not prescribed when

×Active malignancy, or cancer treated within the last 5 years
×Known hypersensitivity to sermorelin
×Untreated hypothyroidism, which blunts the GH response
×Pregnancy, planned pregnancy, or breastfeeding